REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Pharmaroll Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: PHARMAROLL Gyogyszerkiskereskedelmi Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Pharmaroll Bt. is an enterprise in Hungary, with the main office in Szombathely. It operates in the Pharmacies and Drug Stores industry. It was first established on October 06, 1997. 6 (2024) employees currently work for Pharmaroll Bt.. In 2023, the company reported a net sales revenue increase of 12.3%. Its’ total assets recorded a growth of 65.46%. Pharmaroll Bt.’s net profit margin increased by 0.01% in 2023.

Headquarters
Szurcsapo u. 23.
Szombathely; Vas; Postal Code: 9700

Contact Details: Purchase the Pharmaroll Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Pharmaroll Bt. report to view the information.
Outstanding Shares:
Purchase the Pharmaroll Bt. report to view the information.
Registered Capital:
Purchase the Pharmaroll Bt. report to view the information.
Financial Auditors:
Purchase the Pharmaroll Bt. report to view the information.
Incorporation Date:
October 06, 1997
Key Executives
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Pharmaroll Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
12.3%▲
Total operating revenue
12.26%▲
Operating profit (EBIT)
85.87%▲
EBITDA
105.82%▲
Net Profit (Loss) for the Period
14.03%▲
Total assets
65.46%▲
Total equity
13.8%▲
Operating Profit Margin (ROS)
0.7%▲
Net Profit Margin
0.01%▲
Return on Equity (ROE)
0.2%▲
Quick Ratio
-0.11%▼
Cash Ratio
-0.01%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo